Critical

Clozapine-associated emergency

Agranulocytosis / myocarditis · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Clozapine can cause life-threatening agranulocytosis, myocarditis (especially in the first weeks), severe constipation/ileus, seizures and toxicity. Any unwell clozapine patient needs FBC, an ECG/troponin and a low threshold to stop the drug.

Assessment

Investigations

  • FBC (neutropenia/agranulocytosis)
  • ECG + troponin + CRP (myocarditis)
  • Assess for ileus/constipation
  • Clozapine level if toxicity suspected

Management

  • Stop clozapine if agranulocytosis, myocarditis or severe toxicity
  • Neutropenic sepsis pathway if febrile and neutropenic
  • Treat myocarditis supportively; cardiology involvement
  • Manage constipation/ileus aggressively (risk of perforation)
  • Liaise with psychiatry before restarting

Drugs & doses

Empirical antibiotics per BNF — see the in-app Antibiotic Dosing tool
Supportive care

Disposition

Medical admission; liaise psychiatry.

A breathless or febrile patient in the first weeks of clozapine - exclude myocarditis and agranulocytosis before anything else. Antibiotic doses per BNF (current edition); confirm choice in the in-app Antibiotic Dosing tool.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.